Benzinga··Vandana SinghEli Lilly Phases Out Select European Insulin Products by 2027
Eli Lilly discontinuing select insulin products across EU/EEA by Q2 2027 due to commercial factors. Company's experimental retatrutide shows strong diabetes and weight-loss results.
LLYweight lossEurope